gRNA 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 제품 및 서비스별(제품, 커스텀 gRNA 합성 서비스), 용도별, 최종 용도별, 지역별, 경쟁 예측(2020-2030년)

gRNA Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product & Services (Product, Custom gRNA Synthesis Services), By Application, By End-Use, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,561,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,019,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,664,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 gRNA 시장은 2024년에 5억 5,900만 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 19.20%를 나타내 16억 352만 달러에 달할 것으로 예상되고 있습니다.

가이드 RNA(gRNA)는 CRISPR-Cas9 유전자 편집 시스템에서 핵심적인 역할을 하는 합성 RNA 분자로, Cas9 뉴클레아제를 특정 DNA 서열로 정확하게 유도하고 그 변형을 가능하게 합니다. 세계의 gRNA 시장의 성장은 주로 유전자 편집 기술의 현저한 진보, 유전성 질환의 세계 증가에 따른 신규 유전자 치료법에 대한 수요 증가, 생물의학 연구 및 농업 분야에서의 응용 범위의 확대에 의해 견인되고 있습니다. 바이오테크놀러지의 연구개발에 대한 많은 투자는 시장 확대를 더욱 촉진하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	5억 5,900만 달러
시장 규모(2030년)	16억 352만 달러
CAGR(2025-2030년)	19.20%
가장 빠르게 성장하는 부문	제약 및 바이오테크놀러지 기업
가장 큰 시장	북미

주요 시장 성장 촉진요인

세계의 gRNA 시장의 확대는 gRNA 분자가 직접 실현하는 기반 기술인 유전자 편집을 위한 CRISPR-Cas 시스템의 보급에 의해 크게 추진되고 있습니다. CRISPR 기반 치료법의 임상적 유효성 검증과 상업화의 진전은 이러한 보급을 여실히 보여줍니다.

주요 시장 과제

복잡하고 불균일한 세계 규제 상황은 세계 gRNA 시장의 성장에 큰 장벽이 되었습니다. 국가와 지역마다 다른 규제로 인해 제품 승인에는 광범위하고 중복되는 프로세스가 필요하며, 개발 비용의 직접적인 증가와 상업화까지의 기간의 장기화를 초래하고 있습니다.

주요 시장 동향

임상 응용을 위한 GMP 등급 gRNA의 출현은 유전자 편집 기술이 조사 단계에서 치료 제품으로 전환하는 데 중요한 전환점이 됩니다. 이는 gRNA 분자에 대한 엄격한 적절한 제조 기준(GMP)을 요구하며, 임상시험 및 시장에 투입되는 유전자 치료의 안전성, 순도, 효능을 보장합니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 gRNA 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 유형별(연구용, GMP 등급)
  • 제품 및 서비스별(제품, 맞춤형 gRNA 합성 서비스)
  • 용도별(유전체 공학, 질병 모델 연구, 기능 유전체학, 후성유전학, 기타)
  • 최종 용도별(제약 및 바이오테크놀러지 기업, 학술연구기관, CMO 및 CRO)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 gRNA 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 gRNA 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 gRNA 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 gRNA 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카

제10장 남미의 gRNA 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병 및 인수
• 제품 출시
• 최근 동향

제13장 세계의 gRNA 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• System Biosciences, LLC
• Jena Bioscience GmbH
• Merck KGaA
• Azenta US, Inc.
• Takara Bio, Inc.
• Synbio Technologies
• Revvity, Inc.
• Synthego Corporation

제16장 전략적 제안

제17장 기업 소개와 면책사항

KTH

영문 목차

영문목차

The Global gRNA Market, valued at USD 559.00 Million in 2024, is projected to experience a CAGR of 19.20% to reach USD 1603.52 Million by 2030. Guide RNA (gRNA) is a synthetic RNA molecule serving as a pivotal component within the CRISPR-Cas9 genome editing system, precisely directing the Cas9 nuclease to target specific DNA sequences for modification. The global gRNA market's growth is primarily driven by significant advancements in gene editing technologies, the increasing global prevalence of genetic disorders leading to higher demand for novel gene therapies, and expanding applications across biomedical research and agriculture. Substantial investment in biotechnology research and development further propels market expansion.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 559.00 Million
Market Size 2030	USD 1603.52 Million
CAGR 2025-2030	19.20%
Fastest Growing Segment	Pharmaceutical & Biotechnology Companies
Largest Market	North America

Key Market Drivers

The global gRNA market's expansion is significantly propelled by the widespread adoption of CRISPR-Cas systems for gene editing, a foundational technology that gRNA molecules directly enable. The increasing clinical validation and commercialization of CRISPR-based therapies exemplify this adoption. For instance, according to Vertex's Q3 2024 financial report, 40 individuals have entered the treatment process for Casgevy, the first approved CRISPR-based medicine, demonstrating tangible progress in patient access and therapeutic application.

Key Market Challenges

The complex and heterogeneous global regulatory landscape represents a significant impediment to the growth of the Global gRNA Market. Diverse national and regional regulations necessitate extensive and often duplicative processes for product approval, directly escalating development costs and extending timelines for commercialization. This regulatory fragmentation consumes substantial financial and human resources, which could otherwise be directed towards scientific innovation and market penetration. The inherent uncertainty and varying requirements across jurisdictions also deter investment, particularly from smaller entities, thereby limiting the pipeline of novel gRNA-based applications.

Key Market Trends

The emergence of GMP-grade gRNA for clinical applications represents a pivotal shift as gene editing technologies transition from research to therapeutic products, necessitating stringent Good Manufacturing Practice standards for gRNA molecules. This ensures the safety, purity, and efficacy of gene therapies entering trials and the market. The escalating pipeline of gene therapy candidates directly fuels demand for high-quality gRNA manufacturing solutions.

Key Market Players

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• System Biosciences, LLC
• Jena Bioscience GmbH
• Merck KGaA
• Azenta US, Inc.
• Takara Bio, Inc.
• Synbio Technologies
• Revvity, Inc.
• Synthego Corporation

Report Scope:

In this report, the Global gRNA Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

gRNA Market, By Type:

• Research-Use
• GMP-grade

gRNA Market, By Product & Services:

• Product
• Custom gRNA Synthesis Services

gRNA Market, By Application:

• Genome Engineering
• Disease Model Studies
• Functional Genomics
• Epigenetics
• Others

gRNA Market, By End Use:

• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• CMOs & CROs

gRNA Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global gRNA Market.

Available Customizations:

Global gRNA Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global gRNA Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Research-Use, GMP-grade)
  • 5.2.2. By Product & Services (Product, Custom gRNA Synthesis Services)
  • 5.2.3. By Application (Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Others)
  • 5.2.4. By End Use (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CMOs & CROs)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America gRNA Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product & Services
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States gRNA Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product & Services
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada gRNA Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product & Services
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico gRNA Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product & Services
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe gRNA Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product & Services
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany gRNA Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product & Services
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France gRNA Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product & Services
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom gRNA Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product & Services
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy gRNA Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product & Services
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain gRNA Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product & Services
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific gRNA Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product & Services
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China gRNA Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product & Services
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India gRNA Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product & Services
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan gRNA Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product & Services
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea gRNA Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product & Services
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia gRNA Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product & Services
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa gRNA Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product & Services
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia gRNA Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product & Services
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE gRNA Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product & Services
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa gRNA Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product & Services
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America gRNA Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product & Services
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil gRNA Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product & Services
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia gRNA Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product & Services
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina gRNA Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product & Services
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global gRNA Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies, Inc.
• 15.3. System Biosciences, LLC
• 15.4. Jena Bioscience GmbH
• 15.5. Merck KGaA
• 15.6. Azenta US, Inc.
• 15.7. Takara Bio, Inc.
• 15.8. Synbio Technologies
• 15.9. Revvity, Inc.
• 15.10. Synthego Corporation

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료